OrgUnit's Researchers
(Persons)

Results 1-5 of 20 (Search time: 0.001 seconds).

FullnameTranslated NameEmail
Baker, AmyAmy.BAKER@austin.org.au
Balasubramanian, Adithyaadithya.balasubramanian@austin.org.au
Burgess, Adele NAdele.BURGESS@austin.org.au
Cher, Lawrence MLawrence.CHER@austin.org.au
Fancourt, TinekeTineke.FANCOURT@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 201-220 of 548 (Search time: 0.013 seconds).

Publication YearTitleAuthor(s)
201Apr-2018Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer.Elander, N O; Aughton, K; Ghaneh, P; Neoptolemos, J P; Palmer, D H; Cox, T F; Campbell, F; Costello, E; Halloran, C M; Mackey, J R; Scarfe, A G; Valle, J W; McDonald, A C; Carter, R; Tebbutt, Niall C ; Goldstein, D; Shannon, J; Dervenis, C; Glimelius, B; Deakin, M; Charnley, R M; Anthoney, Alan; Lerch, M M; Mayerle, J; Oláh, A; Büchler, M W; Greenhalf, W
202Mar-2021Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival.Chia, Puey Ling ; Parakh, Sagun ; Russell, Prudence; Gan, Hui K ; Asadi, Khashayar ; Gebski, Val; Murone, Carmel ; Walkiewicz, Marzena; Liu, Zhanqi; Thapa, Bibhusal ; Scott, Fiona E; Scott, Andrew M ; John, Thomas 
203May-2022Factor Xa Inhibition for the Treatment of Venous Thromboembolism Associated With Cancer: A Meta-Analysis of the Randomised Controlled Trials.Murphy, Alexandra C ; Koshy, Anoop N ; Farouque, Omar ; Yeo, Belinda ; Raman, Jaishankar; Kearney, Leighton G ; Yudi, Matias B 
20415-May-2016Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.Liu, Geoffrey; Tu, Dongsheng; Lewis, Marcia; Cheng, Dangxiao; Sullivan, Leslie A; Chen, Zhuo; Morgen, Eric; Simes, John; Price, Timothy J; Tebbutt, Niall C ; Shapiro, Jeremy D; Jeffery, G Mark; Mellor, J Daniel; Mikeska, Thomas; Virk, Shakeel; Shepherd, Lois E; Jonker, Derek J; O'Callaghan, Christopher J ; Zalcberg, John R; Karapetis, Christos S; Dobrovic, Alexander 
20520-Nov-2023The features and management of acquired resistance to PD1-based therapy in metastatic melanoma.Hepner, Adriana; Versluis, Judith M; Wallace, Roslyn; Allayous, Clara; Brown, Lauren Julia; Trojaniello, Claudia; Gerard, Camille Lea; Jansen, Yanina Jl; Bhave, Prachi; Neyns, Bart; Haydon, Andrew; Michielin, Olivier; Mangana, Joanna; Klein, Oliver ; Shoushtari, Alexander N; Warner, Allison Betof; Ascierto, Paolo Antonio; McQuade, Jennifer Leigh; Carlino, Matteo S; Zimmer, Lisa; Lebbe, Celeste; Johnson, Douglas B; Sandhu, Shahneen; Atkinson, Victoria; Blank, Christian U; Lo, Serigne N; Long, Georgina V; Menzies, Alexander M
20615-Sep-2020First clinical study of a pegylated diabody 124I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers.Scott, Andrew M ; Akhurst, Timothy; Lee, Fook-Thean; Ciprotti, Marika; Davis, Ian D; Weickhardt, Andrew J ; Gan, Hui K ; Hicks, Rodney J; Lee, Sze Ting ; Kocovski, Pece; Guo, Nancy; Oh, Maggie; Mileshkin, Linda; Williams, Scott; Murphy, Declan; Pathmaraj, Kunthi ; O'Keefe, Graeme J; Gong, Sylvia J; Pedersen, John S; Scott, Fiona E; Wheatcroft, Michael P; Hudson, Peter J
207Nov-2020"First Do No Harm": Significance of Delays from Diagnosis to Surgery in Patients with Non-metastatic Breast Cancer.Xu, Jennifer; Bromley, Luke; Chew, Grace ; Yeo, Belinda 
208Dec-2015First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma.Whittle, James R; Lickliter, Jason D; Gan, Hui K ; Scott, Andrew M ; Simes, John; Solomon, Benjamin J; MacDiarmid, Jennifer A; Brahmbhatt, Himanshu; Rosenthal, Mark A
20915-Aug-2019First-in-Human Phase I Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics and Anti-Tumor Activity.Gan, Hui K ; Millward, Michael J; Hua, Ye; Qi, Chuan; Sai, Yang; Su, Weiguo; Wang, Jian; Zhang, Lilin; Frigault, Melanie M; Morgan, Shethah; Yang, Liu; Lickliter, Jason D
210Apr-2022First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.John, Thomas ; Sakai, Hiroshi; Ikeda, Satoshi; Cheng, Ying; Kasahara, Kazuo; Sato, Yuki; Nakahara, Yoshiro; Takeda, Masayuki; Kaneda, Hiroyasu; Zhang, Helong; Maemondo, Makoto; Minato, Koichi; Hisada, Takeshi; Misumi, Yuki; Satouchi, Miyako; Hotta, Katsuyuki; Li, Ang; Oukessou, Abderrahim; Lu, Shun
211Feb-2021First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.Paz-Ares, Luis; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Sakai, Hiroshi; Lingua, Alejo; Salman, Pamela; Souquet, Pierre-Jean; De Marchi, Pedro; Martin, Claudio; Pérol, Maurice; Scherpereel, Arnaud; Lu, Shun; John, Thomas ; Carbone, David P; Meadows-Shropshire, Stephanie; Agrawal, Shruti; Oukessou, Abderrahim; Yan, Jinchun; Reck, Martin
2121-Oct-2021First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.Reck, M; Ciuleanu, T-E; Cobo, M; Schenker, M; Zurawski, B; Menezes, J; Richardet, E; Bennouna, J; Felip, E; Juan-Vidal, O; Alexandru, A; Sakai, H; Lingua, A; Reyes, F; Souquet, P-J; De Marchi, P; Martin, C; Pérol, M; Scherpereel, A; Lu, S; Paz-Ares, L; Carbone, D P; Memaj, A; Marimuthu, S; Zhang, X; Tran, P; John, Thomas 
21328-Jan-2023First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes.Reck, Martin; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Cheng, Ying; Sakai, Hiroshi; Paz-Ares, Luis; Lu, Shun; John, Thomas ; Sun, Xiaowu; Moisei, Aniela; Taylor, Fiona; Lawrance, Rachael; Zhang, Xiaoqing; Sylvester, Judi; Yuan, Yong; Blum, Steven I; Penrod, John R; Carbone, David P
214Jan-2020Gefitinib and Pemetrexed Improve Survival in EGFR-Mutated NSCLC - Tarring all Patients With the Same Brush?Arulananda, Surein; John, Thomas 
21522-Nov-2019Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets.Lau, David K ; Mouradov, Dmitri; Wasenang, Wiphawan; Luk, Ian Y; Scott, Cameron M; Williams, David S ; Yeung, Yvonne H ; Limpaiboon, Temduang; Iatropoulos, George F ; Jenkins, Laura J; Reehorst, Camilla M; Chionh, Fiona; Nikfarjam, Mehrdad ; Croagh, Daniel; Dhillon, Amardeep S; Weickhardt, Andrew J ; Muramatsu, Toshihide; Saito, Yoshimasa; Tebbutt, Niall C ; Sieber, Oliver M; Mariadason, John M 
2163-Jan-2023Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death.Jenkins, Laura J; Luk, Ian Y; Fairlie, Walter Douglas ; Lee, Erinna F; Palmieri, Michelle; Schoffer, Kael L; Tan, Tao; Ng, Irvin; Vukelic, Natalia; Tran, Sharon; Tse, Janson W T; Nightingale, Rebecca; Alam, Zakia; Chionh, Fiona; Iatropoulos, George F ; Ernst, Matthias ; Afshar-Sterle, Shoukat ; Desai, Jayesh; Gibbs, Peter; Sieber, Oliver M; Dhillon, Amardeep S ; Tebbutt, Niall C ; Mariadason, John M 
2179-Jun-2022Glioma progression is shaped by genetic evolution and microenvironment interactions.Varn, Frederick S; Johnson, Kevin C; Martinek, Jan; Huse, Jason T; Nasrallah, MacLean P; Wesseling, Pieter; Cooper, Lee A D; Malta, Tathiane M; Wade, Taylor E; Sabedot, Thais S; Brat, Daniel; Gould, Peter V; Wöehrer, Adelheid; Aldape, Kenneth; Ismail, Azzam; Sivajothi, Santhosh K; Barthel, Floris P; Kim, Hoon; Kocakavuk, Emre; Ahmed, Nazia; White, Kieron; Datta, Indrani; Moon, Hyo-Eun; Pollock, Steven; Goldfarb, Christine; Lee, Ga-Hyun; Garofano, Luciano; Anderson, Kevin J; Nehar-Belaid, Djamel; Barnholtz-Sloan, Jill S; Bakas, Spyridon; Byrne, Annette T; D'Angelo, Fulvio; Gan, Hui K ; Khasraw, Mustafa; Migliozzi, Simona; Ormond, D Ryan; Paek, Sun Ha; Van Meir, Erwin G; Walenkamp, Annemiek M E; Watts, Colin; Weiss, Tobias; Weller, Michael; Palucka, Karolina; Stead, Lucy F; Poisson, Laila M; Noushmehr, Houtan; Iavarone, Antonio; Verhaak, Roel G W
2188-Feb-2018Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium.Aldape, Kenneth; Amin, Samirkumar B; Ashley, David M; Barnholtz-Sloan, Jill S; Bates, Amanda J; Beroukhim, Rameen; Bock, Christoph; Brat, Daniel J; Claus, Elizabeth B; Costello, Joseph F; de Groot, John F; Finocchiaro, Gaetano; French, Pim J; Gan, Hui K ; Griffith, Brent; Herold-Mende, Christel C; Horbinski, Craig; Iavarone, Antonio; Kalkanis, Steven N; Karabatsou, Konstantina; Kim, Hoon; Kouwenhoven, Mathilde C M; McDonald, Kerrie L; Miletic, Hrvoje; Nam, Do-Hyun; Ng, Ho Keung; Niclou, Simone P; Noushmehr, Houtan; Ormond, Ryan; Poisson, Laila M; Reifenberger, Guido; Roncaroli, Federico; Sa, Jason K; Sillevis Smitt, Peter A E; Smits, Marion; Souza, Camila F; Tabatabai, Ghazaleh; Van Meir, Erwin G; Verhaak, Roel G W; Watts, Colin; Wesseling, Pieter; Woehrer, Adelheid; Yung, W K Alfred; Jungk, Christine; Hau, Ann-Christin; van Dyck, Eric; Westerman, Bart A; Yin, Julia; Abiola, Olajide; Zeps, Nikolaj; Grimmond, Sean; Buckland, Michael; Khasraw, Mustafa; Sulman, Erik P; Muscat, Andrea M; Stead, Lucy
2193-Feb-2014The growing burden of multidrug-resistant infections among returned Australian travellers.Chua, Kyra Y L ; Grayson, M Lindsay ; Burgess, Adele N ; Lee, Jean Y H; Howden, Benjamin P 
220Jul-2017Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastomaField, Kathryn M; King, Madeleine T; Simes, John; Espinoza, David; Barnes, Elizabeth H; Sawkins, Kate; Rosenthal, Mark A; Cher, Lawrence M ; Hovey, Elizabeth; Wheeler, Helen; Nowak, Anna K